Dear Brad,
This document was written by Bradford Perez, then a third-year medical student, in late March or early April 2008. Working in the laboratory of Anil Potti, Perez presented what biostatisticians describe as an excellent critique of the flawed methodology employed Duke genomics researchers.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL received a pledge of $2 million over the next 10 years from InfinityQS International Inc.
FDA approved an updated version of MarginProbe, a medical device that enables real-time detection of cancer at the surface of excised tissue specimens during breast-conserving cancer surgery. MarginProbe is developed by Dune Medical Devices.
NIPUN MERCHANT is joining the Sylvester Comprehensive Cancer Center as chief surgical officer and director of Surgical Oncology Research Programs.
Joseph McLaughlin, an internationally recognized epidemiologist who made numerous contributions towards increasing understanding of the causes of cancer, died unexpectedly Dec. 10, 2014.
FDA approved Opdivo (nivolumab) injection for the treatment of patients with unresectable or metastatic melanoma and disease progression following Yervoy (ipilimumab) and, if BRAF V600 mutation positive, a BRAF inhibitor.
SHARMILA MAKHIJA was named professor and chair of the Department of Obstetrics & Gynecology and Women's Health at Albert Einstein College of Medicine and Montefiore Health System, effective April 1.
DONALD “SKIP” TRUMP was named the first CEO and executive director of the newly created Inova Cancer Care and Research Institute, part of the Inova Health System.
New Perspective on Nevins and Potti
